Skip to main content
Fig. 2 | BMC Nephrology

Fig. 2

From: Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy

Fig. 2

Proposed algorithm to guide the decision on anticoagulant management in primary MN patients with VTE. MN: membranous nephropathy; VTE: venous thromboembolic event; DVT: deep venous thrombosis; PE: pulmonary embolism; AC: anticoagulation; m: month; d: days; VKA: vitamin K antagonists; DOAC: direct oral anticoagulant; w: weeks; LMWH: low molecular weight heparin; US: ultrasound surveillance

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us